Combination antifungal therapy for the treatment of invasive yeast and mold infections

被引：16
|
作者：
Baddley J.W. [1 ]
Pappas P.G. [1 ]
机构：
[1] University of Alabama at Birmingham, Department of Medicine, Division of Infectious Diseases, Birmingham, AL 35294-0006
来源：
Current Infectious Disease Reports | 2007年 / 9卷 / 6期
关键词：
Voriconazole; Aspergillosis; Invasive Aspergillosis; Antimicrob Agent; Caspofungin;
D O I：
10.1007/s11908-007-0069-1
中图分类号：
学科分类号：
摘要：
Combination antifungal therapy has been an area of great research and clinical interest since antifungals became available decades ago, in part driven by the severe morbidity and mortality associated with invasive fungal infections. Because of the availability of newer antifungal agents including echinocandins and expanded-spectrum triazoles, interest in combination antifungal therapy for invasive mold disease, especially invasive aspergillosis, has grown. This review examines combination antifungal therapy for the treatment of yeast and molds, including current studies evaluating combination antifungal therapy in three clinically important invasive fungal infections: candidiasis, cryptococcosis, and aspergillosis. This article focuses on recent clinical data and potential future clinical directions. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：448 / 456
页数：8
相关论文
共 50 条
  • [1] Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination
    Rojas, Rafael
    Molina, Jose R.
    Jarque, Isidro
    Montes, Carmen
    Serrano, Josefina
    Sanz, Jaime
    Besalduch, Juan
    Carreras, Enric
    Tomas, Jose F.
    Madero, Luis
    Rubio, Daniel
    Conde, Eulogio
    Sanz, Miguel A.
    Torres, Antonio
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2012, 4 (01):
  • [2] Antifungal combination therapy in invasive fungal infections
    Gellen-Dautremer, J.
    Lanternier, F.
    Dannaoui, E.
    Lortholary, O.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 (01): : 72 - 81
  • [3] Combination therapy for the treatment of pulmonary mold infections
    McCarthy, Matthew William
    Petraitis, Vidmantas
    Walsh, Thomas J.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (06) : 481 - 489
  • [4] Combination antifungal therapy for mold infections: Much ado about nothing?
    Vazquez, Jose A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) : 1889 - 1901
  • [5] Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
    Brunet, Kevin
    Martellosio, Jean-Philippe
    Tewes, Frederic
    Marchand, Sandrine
    Rammaert, Blandine
    [J]. PHARMACEUTICS, 2022, 14 (03)
  • [6] Combination antifungal therapy for invasive fungal infections in children and adults
    Hatipoglu, Nevin
    Hatipoglu, Husem
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (05) : 523 - 535
  • [7] Combination antifungal therapy: A strategy for the management of invasive fungal infections
    Javier Carrillo-Munoz, Alfonso
    Finquelievich, Jorge
    Tur-Tur, Cristina
    Eraso, Elena
    Jauregizar, Nerea
    Quindos, Guillermo
    Giusiano, Gustavo
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2014, 27 (03) : 141 - 158
  • [8] ANTIFUNGAL THERAPY OF YEAST INFECTIONS
    HAY, RJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (03) : S6 - S9
  • [9] Combination antifungal therapy plus IFN gamma in the treatment of rapidly progressing invasive fungal infections
    Kaczmarek, P.
    Evans, S.
    Ethell, M.
    Harrison, T.
    Treleaven, J.
    Morgan, G.
    Potter, M.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S271 - S271
  • [10] Antifungal therapy in invasive fungal infections
    Chen, Sharon C-A
    Playford, E. Geoffrey
    Sorrell, Tania C.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) : 522 - 530
12345